Clinical trial
Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects
NCT01827631 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 27, 2013
- Completion date
- June 25, 2013
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease